Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors

导出原文传递

翻译打印收藏纠错

作者： Schott,A.F. ^[1] ; Landis,M.D. ^[2] ; Dontu,G. ^[3] ; Griffith,K.A. ^[4] ; Layman,R.M. ^[5] ; Krop,I. ^[6] ; Paskett,L.A. ; Wong,H. ; Dobrolecki,L.E. ; Lewis,M.T. ; Froehlich,A.M. ; Paranilam,J. ; Hayes,D.F. ; Wicha,M.S. ; Chang,J.C.

作者单位： Methodist Hospital Research Institute, Baylor College of Medicine, Houston, TX, United States ^[1] Ohio State University, Columbus, OH, United States ^[2] Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, United States ^[3] Dana-Farber Cancer Institute, Boston, MA, United States ^[4] King's College London, School of Medicine, London, United Kingdom ^[5] University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI 48109, United States ^[6]

发布时间 2014-09-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览7

Clinical cancer research

2013年19卷6期

1512-1524页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

检索历史清除